Breaking News Instant updates and real-time market news.

BAC

Bank of America

$22.94

0.39 (1.73%)

, F

Ford

$12.85

0.22 (1.74%)

08:56
01/11/17
01/11
08:56
01/11/17
08:56

Notable open interest changes for January 11th

Tuesday's total option volume of 13.8 million contracts resulted in net open interest growth of 2.22 million calls and 2.71 million puts. Bank of America (BAC), Ford (F), Intel (INTC) and Valeant (VRX) saw the greatest growth. Top five new positions opened include 31k Chesapeake (CHK) Mar-17 7 calls, 25k Intel (INTC) Feb-17 34 puts, 24k Intel (INTC) Feb-17 38 calls, 23k AK Steel (AKS) Feb-17 13 calls and 20k Southwestern Energy (SWN) Feb-17 13 calls.

BAC

Bank of America

$22.94

0.39 (1.73%)

F

Ford

$12.85

0.22 (1.74%)

INTC

Intel

$36.54

-0.07 (-0.19%)

VRX

Valeant

$16.40

1.05 (6.84%)

  • 13

    Jan

  • 16

    Feb

BAC Bank of America
$22.94

0.39 (1.73%)

01/09/17
WELS
01/09/17
NO CHANGE
WELS
Bank of America added to Priority Stock List at Wells Fargo
Wells Fargo added Bank of America to its Priority Stock List and identifies it as its top pick among large cap banks. The firm has "growing confidence" that the bank can benefit from multiple catalysts, including higher rates, prudent balance sheet growth, capital market improvement, and cost reductions.
12/21/16
ATLE
12/21/16
UPGRADE
Target $25
ATLE
Overweight
Bank of America upgraded due rising rates, lower taxes at Atlantic Equities
As previously reported, Atlantic Equities upgraded Bank of America to Overweight from Neutral with a $25 price target. Analyst Christopher Wheeler said Bank of America will be a major beneficiary of rising rates, strong capital markets, and potentially lower tax rates.
01/11/17
UBSW
01/11/17
DOWNGRADE
Target $23
UBSW
Neutral
Bank of America downgraded to Neutral from Buy at UBS
UBS analyst Saul Martinez downgraded Bank of America after assuming coverage of the name. The analyst views the valuation as full following the stock's outperformance since interest rates troughed in mid- 2016. He lowered his price target for the shares to $23 from $24.
01/10/17
SBSH
01/10/17
DOWNGRADE
Target $225
SBSH
Sell
Goldman Sachs downgraded to Sell from Neutral at Citi
Citi analyst Keith Horowitz downgraded Goldman Sachs (GS) to Sell with a $225 price target, representing 6% downside from current levels. While higher interest rates benefit fixed income trading, the path is "relatively uncertain and the bar is relatively high" for Goldman, Horowitz tells investors in a research note. The analyst believes U.S. bank stocks do not offer compelling risk/reward profiles following the recent rally. Horowitz this morning also downgraded Comerica (CMA) to Sell while keeping Buy ratings on Wells Fargo (WFC) and Bank of America (BAC).
F Ford
$12.85

0.22 (1.74%)

12/21/16
12/21/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Boeing (BA) initiated with a Buy at Seaport Global. 2. Qualcomm (QCOM) and NXP Semiconductors (NXPI) were initiated with a Neutral at Citi. 3. Mobileye (MBLY) was initiated with a Market Perform at BMO Capital and a Neutral at Susquehanna. 4. Ford (F) initiated with a Market Perform at BMO Capital. 5. Autoliv (ALV) initiated with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/28/16
PIPR
12/28/16
NO CHANGE
PIPR
Piper lays out top Auto and Truck picks into 2017
Piper Jaffray analyst Alexander Potter ranked his auto- and truck-related stocks in order of conviction heading into 2017. His top three names are General Motors (GM), Delphi (DLPH) and Mobileye (MBLY). Mobileye offers the most "compelling upside potential" at almost 70%, but also the most risk, Potter tells investors in a research note on the Autos, Trucks, and Advanced Mobility space. As such, the stock sits third behind GM and Delphi in order of preference. After a strong showing in 2016, the analyst thinks most of the truck stocks will struggle to outperform in 2017. He calls Allison Transmission (ALSN) a notable Underweight.
01/04/17
JEFF
01/04/17
NO CHANGE
Target $32
JEFF
Buy
Fox Factory price target raised to $32 from $26 at Jefferies
Jefferies analyst Trevor Young raised his price target for Fox Factory (FOXF) to $32 saying his firm's Ford (F) dealer survey bodes well for the company's power vehicle business in Q4 and FY17. The survey indicated long wait lists for the MY17 Ford F-150 Raptor and ask prices up to $20,000 above the suggested retail price for in-stock units. The analyst notes Fox Factory is the suspension supplier for the truck. Young reiterates a Buy rating on the shares.
01/03/17
LOOP
01/03/17
NO CHANGE
LOOP
Ford plant cancelation 'big hit' to Kansas City Southern auto story, says Loop
Loop Capital Markets analyst Rick Paterson said that Ford's (F) cancelled $1.6B investment in a Mexican automotive plant was "a big hit" to the Kansas City Southern (KSU) auto growth story, but noted that the remaining Mexican plant openings were from foreign companies, making them less susceptible to pressure from President-elect Trump. Paterson kept a Buy rating and $98 price target on Kansas City Southern shares.
INTC Intel
$36.54

-0.07 (-0.19%)

01/09/17
FBCO
01/09/17
NO CHANGE
FBCO
Credit Suisse sees continued Semi upside, lays out top 2017 picks
Credit Suisse analyst John Pitzer says that despite outperforming in three of the last four years, shares of Semiconductor companies have more upside. Increasing barriers to entry coupled with slowing supply growth, further industry consolidation and diversifying demand drivers should allow Semis to outgrow global nominal gross domestic product for the first time since the late 1990s, Pitzer tells investors in a research note titled "2017 Outlook: Go Secular or Go Home." He views the Semi space as the "safest/cheapest vehicle with which to exploit Data Growth." Pitzer this morning upgraded Texas Instruments (TXN) to Outperform from Neutral and Brooks Automation (BRKS) to Neutral from Underperform. He also downgraded Rudolph Technologies (RTEC) to Neural. His top picks for 2017 in order of preference are Micron (MU), Texas Instruments, Marvell (MRVL) and Intel (INTC) in Semis and Applied Materials (AMAT), KLA-Tencor (KLAC), and Lam Research (LRCX) in the Semi Equipment space.
12/13/16
LOOP
12/13/16
INITIATION
Target $40
LOOP
Buy
Intel initiated with a Buy at Loop Capital
Loop Capital analyst Betsy Van Hees initiated Intel with a Buy and a $40 price target.
12/14/16
ADAM
12/14/16
NO CHANGE
Target $13
ADAM
Buy
AMD price target raised to $13 from $8.75 at Canaccord
Canaccord analyst Matthew Ramsay raise his price target on Advanced Micro Devices (AMD) to $13 from $8.75 citing higher confidence in the company's CPU and GPU roadmaps and its gross margin expansion opportunity. Ramsay, who sees AMD re-emerging as a competitive second source to Intel (INTC) in CPU markets with its "on-track" Zen roadmap and expects a gradual unit share recovery in lower GPU market tiers, keeps a Buy rating on AMD shares.
12/20/16
12/20/16
UPGRADE
Target $13

Buy
AMD upgraded to Buy on deep learning and AI opportunity at Mizuho
As previously reported, Mizuho analyst Vijay Rakesh upgraded AMD (AMD) to Buy from Neutral, as he sees deep learning and AI as the next big computing paradigm and believes the company has an opportunity for deep learning with its new Radeon ProGFx/Ryzen products. He set a $13 price target on AMD shares. Rakesh, who said NVIDIA (NVDA) has solid traction in the initial Deep Learning space with GPUs and parallelism, raised his price target on its shares to $115 from $80, adding that while Intel (INTC) is a "late starter" and behind NVIDIA, it should also be a beneficiary of GPUs in the data center.
VRX Valeant
$16.40

1.05 (6.84%)

01/11/17
ADAM
01/11/17
NO CHANGE
Target $19
ADAM
Hold
Valeant asset sales first steps to address leverage, says Canaccord
Canaccord analyst Neil Maruoka noted Valeant's asset sales announced yesterday, calling them the company's first steps in addressing the de-leveraging of its balance sheet. He views the moves as a positive, but also said it underscores the potential challenges ahead for the company. Maruoka maintained his Hold rating and raised his price target to $19 from $17 on Valeant shares.
01/10/17
01/10/17
NO CHANGE

Wells Fargo says Valeant debt problematic, base business still weak
Wells Fargo analyst David Maris said the proceeds announced today from Valeant's sale of its Dendreon unit, CeraVe and two other products would cover some, but not all, of the approximately $3.8B in debt the company has due in 2018. Valeant has not made clear in its press releases if these deals are dilutive to EPS, noted Maris, who believes the company's debt is problematic and base business remains weak. Maris keeps an Underperform rating on Valeant shares.
01/10/17
BMOC
01/10/17
NO CHANGE
Target $21
BMOC
Market Perform
Valeant sales of Dendreon, CeraVe a 'good start,' says BMO Capital
BMO Capital analyst Gary Nachman said Valeant's (VRX) sales of Dendreon to Sanpower Group and CeraVe, AcneFree and AMBI to L'Oreal (LRLCY) for roughly $2.1B in cash have a combined average sales multiple of 4.4x, which appears to be a "solid price" and a good start for the company as it looks to sell additional assets to address its debt. Nachman also noted that Valeant announced that its second Phase 3 study for IDP-118 was successful, though he remains cautious on the drug given that most psoriasis creams are generic at this point. The analyst keeps a Market Perform rating and $21 price target on Valeant shares, which are up nearly 13% to $17.31 in pre-market trading.
01/10/17
WELS
01/10/17
NO CHANGE
WELS
Underperform
Valeant hiked prices on over 50 products last week, says Wells Fargo
Wells Fargo analyst David Maris said last night that on January 6, Valeant Pharmaceuticals implemented 95 different price increases across more than 50 products. This shows the company continues to rely on price as a means of growth and may also signal that Valeant's prescription volumes continue to remain challenged, Maris told investors in a research note. He reminds investors that Friday's price hikes "come on top of significant price increases--some of them more than 100%--taken on products in previous years and several taken in late 2016." Maris continues to believe the "new Valeant" is the "same Valeant using the same strategy and pricing levers that have been used before." The analyst keeps an Underperform rating on the shares with a $10-$13 price target range. The stock is up 12% to $17.20 in pre-market trading following the announcement of several asset sales.

TODAY'S FREE FLY STORIES

BMS

Bemis

$44.90

-0.28 (-0.62%)

20:30
06/22/17
06/22
20:30
06/22/17
20:30
Upgrade
Bemis rating change at BMO Capital »

Bemis upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATUS

Altice USA

20:29
06/22/17
06/22
20:29
06/22/17
20:29
Initiation
Altice USA initiated at Pivotal Research »

Altice USA initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

BBRY

BlackBerry

$11.06

0.41 (3.85%)

, FINL

Finish Line

$12.73

0.23 (1.84%)

20:25
06/22/17
06/22
20:25
06/22/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BBRY

BlackBerry

$11.06

0.41 (3.85%)

FINL

Finish Line

$12.73

0.23 (1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 23

    Jun

NBRV

Nabriva Therapeutics

$10.50

1.19 (12.78%)

20:22
06/22/17
06/22
20:22
06/22/17
20:22
Initiation
Nabriva Therapeutics initiated at Cantor »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jul

WIX

Wix.com

$72.80

0.5 (0.69%)

20:20
06/22/17
06/22
20:20
06/22/17
20:20
Initiation
Wix.com initiated at Wedbush »

Wix.com initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

OCLR

Oclaro

$9.44

-0.1 (-1.05%)

20:19
06/22/17
06/22
20:19
06/22/17
20:19
Initiation
Oclaro initiated at DA Davidson »

Oclaro initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 26

    Jun

ACIA

Acacia Communications

$41.64

0.65 (1.59%)

20:19
06/22/17
06/22
20:19
06/22/17
20:19
Initiation
Acacia Communications initiated at DA Davidson »

Acacia Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 26

    Jun

LITE

Lumentum

$62.45

-0.05 (-0.08%)

20:19
06/22/17
06/22
20:19
06/22/17
20:19
Initiation
Lumentum initiated at DA Davidson »

Lumentum initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 26

    Jun

LEJU

Leju

$2.46

0.07 (2.93%)

20:05
06/22/17
06/22
20:05
06/22/17
20:05
Downgrade
Leju rating change at JPMorgan »

Leju downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GCP

GCP Applied Technologies

$30.40

0.3 (1.00%)

20:04
06/22/17
06/22
20:04
06/22/17
20:04
Upgrade
GCP Applied Technologies rating change at KeyBanc »

GCP Applied Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHM

PulteGroup

$24.04

-0.24 (-0.99%)

19:58
06/22/17
06/22
19:58
06/22/17
19:58
Initiation
PulteGroup initiated at Credit Suisse »

PulteGroup initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHI

D.R. Horton

$33.47

-0.5 (-1.47%)

19:58
06/22/17
06/22
19:58
06/22/17
19:58
Initiation
D.R. Horton initiated at Credit Suisse »

D.R. Horton initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAA

CalAtlantic

$34.80

-0.34 (-0.97%)

19:57
06/22/17
06/22
19:57
06/22/17
19:57
Initiation
CalAtlantic initiated at Credit Suisse »

CalAtlantic initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BZH

Beazer Homes

$13.01

0.03 (0.23%)

19:57
06/22/17
06/22
19:57
06/22/17
19:57
Initiation
Beazer Homes initiated at Credit Suisse »

Beazer Homes initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTH

Meritage Homes

$40.40

-0.4 (-0.98%)

19:57
06/22/17
06/22
19:57
06/22/17
19:57
Initiation
Meritage Homes initiated at Credit Suisse »

Meritage Homes initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

19:57
06/22/17
06/22
19:57
06/22/17
19:57
Initiation
Toll Brothers initiated at Credit Suisse »

Toll Brothers initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$52.41

-0.84 (-1.58%)

19:57
06/22/17
06/22
19:57
06/22/17
19:57
Initiation
Lennar initiated at Credit Suisse »

Lennar initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBH

KB Home

$22.23

-0.1 (-0.45%)

19:57
06/22/17
06/22
19:57
06/22/17
19:57
Initiation
KB Home initiated at Credit Suisse »

KB Home initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

MHK

Mohawk

$242.70

-0.22 (-0.09%)

19:27
06/22/17
06/22
19:27
06/22/17
19:27
Initiation
Mohawk initiated at Credit Suisse »

Mohawk initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBHS

Fortune Brands

$65.09

0.06 (0.09%)

19:27
06/22/17
06/22
19:27
06/22/17
19:27
Initiation
Fortune Brands initiated at Credit Suisse »

Fortune Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

JELD-WEN Holding

$34.60

-0.29 (-0.83%)

19:26
06/22/17
06/22
19:26
06/22/17
19:26
Initiation
JELD-WEN Holding initiated at Credit Suisse »

JELD-WEN Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBP

Installed Building Products

$52.75

-1 (-1.86%)

19:26
06/22/17
06/22
19:26
06/22/17
19:26
Initiation
Installed Building Products initiated at Credit Suisse »

Installed Building…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OC

Owens Corning

$66.42

-0.85 (-1.26%)

19:26
06/22/17
06/22
19:26
06/22/17
19:26
Initiation
Owens Corning initiated at Credit Suisse »

Owens Corning initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WHR

Whirlpool

$195.16

1.35 (0.70%)

19:26
06/22/17
06/22
19:26
06/22/17
19:26
Initiation
Whirlpool initiated at Credit Suisse »

Whirlpool initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAS

Masco

$38.82

0.06 (0.15%)

19:26
06/22/17
06/22
19:26
06/22/17
19:26
Initiation
Masco initiated at Credit Suisse »

Masco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.